MAP
Madison Avenue Partners Portfolio holdings
AUM
$1.5B
This Quarter Return
-2.63%
1 Year Return
+26.66%
3 Year Return
+137.23%
5 Year Return
+278.64%
10 Year Return
–
AUM
$792M
AUM Growth
+$792M
(+28%)
Cap. Flow
+$165M
Cap. Flow
% of AUM
20.79%
Top 10 Holdings %
Top 10 Hldgs %
92.65%
Holding
24
New
6
Increased
8
Reduced
3
Closed
4
Top Buys
| 1 |
Solventum
SOLV
|
$130M |
| 2 |
QuidelOrtho
QDEL
|
$49.7M |
| 3 |
Globus Medical
GMED
|
$48.8M |
| 4 |
Ducommun
DCO
|
$22.2M |
| 5 |
Graham Holdings Company
GHC
|
$15.9M |
Top Sells
| 1 |
SharkNinja
SN
|
$81.6M |
| 2 |
HES
Hess
HES
|
$45.8M |
| 3 |
ONL
Orion Office REIT
ONL
|
$9.19M |
| 4 |
HomeStreet
HMST
|
$7.57M |
| 5 |
MACK
Merrimack Pharmaceuticals, Inc.
MACK
|
$5.72M |
Sector Composition
| 1 | Healthcare | 46.84% |
| 2 | Consumer Staples | 20.63% |
| 3 | Communication Services | 16.22% |
| 4 | Consumer Discretionary | 8.36% |
| 5 | Financials | 4.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Graham Holdings Company
GHC
$4.74B
| $163M | 20.63% | 233,484 +22,767 | +11% | +$15.9M |
|
|
2
Solventum
SOLV
$12.7B
| $130M | 16.47% | +2,464,934 | New | +$130M |
|
|
3
Globus Medical
GMED
$8.27B
| $97M | 12.25% | 1,416,168 +712,892 | +101% | +$48.8M |
|
4
Theravance Biopharma
TBPH
$699M
| $72.2M | 9.12% | 8,511,350 +1,499,124 | +21% | +$12.7M |
|
5
John Wiley & Sons Class A
WLY
$2.16B
| $66.4M | 8.38% | 1,630,517 +263,746 | +19% | +$10.7M |
|
|
6
SharkNinja
SN
$16.5B
| $54.2M | 6.85% | 721,578 -1,085,659 | -60% | -$81.6M |
|
|
7
QuidelOrtho
QDEL
$1.95B
| $49.7M | 6.28% | +1,497,148 | New | +$49.7M |
|
8
Stagwell
STGW
$1.46B
| $48.7M | 6.16% | 7,147,662 | – | – |
|
9
Nelnet
NNI
$4.65B
| $29.3M | 3.7% | 290,213 | – | – |
|
|
10
Ducommun
DCO
$1.36B
| $22.2M | 2.81% | +382,495 | New | +$22.2M |
|
11
Atmus Filtration Technologies
ATMU
$3.66B
| $12M | 1.51% | 415,366 +338,634 | +441% | +$9.75M |
|
12
News Corp Class A
NWSA
$16.6B
| $11.8M | 1.49% | +428,040 | New | +$11.8M |
|
|
TSVT
13
DELISTED
2seventy bio
TSVT
| $9.87M | 1.25% | 2,563,222 +130,000 | +5% | +$501K |
|
|
FSP
14
Franklin Street Properties
FSP
$172M
| $5.04M | 0.64% | 3,291,443 | – | – |
|
15
ZimVie
ZIMV
$532M
| $4.94M | 0.62% | +270,927 | New | +$4.94M |
|
16
Indivior
INDV
$3.03B
| $3.6M | 0.46% | 223,432 +60,537 | +37% | +$976K |
|
|
CEE
17
Central and Eastern Europe Fund
CEE
$105M
| $3.59M | 0.45% | 337,046 -85,777 | -20% | -$914K |
|
18
Ovid Therapeutics
OVID
$91M
| $3.14M | 0.4% | 4,082,100 +433,591 | +12% | +$334K |
|
|
19
HomeStreet
HMST
$262M
| $2.75M | 0.35% | 240,903 -664,119 | -73% | -$7.57M |
|
20
News Corp Class B
NWS
$19.1B
| $1.49M | 0.19% | +52,534 | New | +$1.49M |
|
21
Gossamer Bio
GOSS
$562M
| – | – | -4,140,773 | Closed | -$4.89M |
|
|
HES
22
DELISTED
Hess
HES
| – | – | -300,270 | Closed | -$45.8M |
|
|
ONL
23
Orion Office REIT
ONL
$167M
| – | – | -2,618,529 | Closed | -$9.19M |
|
|
MACK
24
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| – | – | -387,221 | Closed | -$5.72M |
|